Observational studyMedical oncology (Northwood, London, England)2014

How to determine post-FCR therapy for cytogenetic risk-tailored elderly patients with chronic lymphocytic leukemia, maintenance rituximab or observation.

Bin-Tao Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.